logo-large
  • Browse Categories

Publications by authors named "Ingrid Bechtold"

Claim this Profile
E
EPICYCLE: A confirmatory preclinical study of the anti-rhabdomyosarcoma efficacy of BET bromodomain and cyclin-dependent kinase 9 inhibitors.
Bernhard Haller, Günther H S Richter, Marco Wachtel, Lena Schuler, Carla Regina, Ingrid Bechtold

Biomed Pharmacother· November 2025


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-derived tumoroids from CIC::DUX4 rearranged sarcoma identify MCL1 as a therapeutic target.
Willemijn Breunis, Eva Brack, Anna C Ehlers, Ingrid Bechtold, Samanta Kisele

Nat Commun· August 2025


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-cell profiling of alveolar rhabdomyosarcoma reveals RAS pathway inhibitors as cell-fate hijackers with therapeutic relevance.
Sara G Danielli, Ermelinda Porpiglia, Andrea J De Micheli, Natalia Navarro, Michael J Zellinger, Ingrid Bechtold

Sci Adv· February 2023


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficient processes for protein expression using recombinant baculovirus particles.
Heike Cremer, Ingrid Bechtold, Marion Mahnke, René Assenberg

Methods Mol Biol· August 2014


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: